0.3186 USD
-0.01 (-3.22%)
0.3161 USD
0 (-0.78%)
Taking everything into account, PAVM scores 3 out of 10 in our fundamental rating. PAVM was compared to 188 industry peers in the Health Care Equipment & Supplies industry. PAVM has a bad profitability rating. Also its financial health evaluation is rather negative. PAVM shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
PAVM had negative earnings in the past year.
In the past year PAVM has reported a negative cash flow from operations.
In the past 5 years PAVM reported 4 times negative net income.
PAVM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
PAVM has a Return On Assets of 159.59%. This is amongst the best in the industry. PAVM outperforms 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 171.73%, PAVM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 159.59% | ||
| ROE | 171.73% | ||
| ROIC | N/A |
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 6867.55%, PAVM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Operating Margin and Gross Margin are not available for PAVM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 6867.55% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
PAVM has more shares outstanding than it did 1 year ago.
PAVM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PAVM has been reduced compared to a year ago.
2.2 Solvency
PAVM has an Altman-Z score of -8.37. This is a bad value and indicates that PAVM is not financially healthy and even has some risk of bankruptcy.
PAVM has a worse Altman-Z score (-8.37) than 76.06% of its industry peers.
PAVM has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, PAVM is doing good in the industry, outperforming 60.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.37 |
ROIC/WACCN/A
WACC6%
2.3 Liquidity
A Current Ratio of 0.52 indicates that PAVM may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.52, PAVM is doing worse than 93.09% of the companies in the same industry.
PAVM has a Quick Ratio of 0.52. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
PAVM's Quick ratio of 0.52 is on the low side compared to the rest of the industry. PAVM is outperformed by 92.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 90.43% over the past year.
Looking at the last year, PAVM shows a very strong growth in Revenue. The Revenue has grown by 22.15%.
PAVM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.61% yearly.
EPS 1Y (TTM)90.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.14%
Revenue 1Y (TTM)22.15%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%
3.2 Future
The Earnings Per Share is expected to grow by 26.79% on average over the next years. This is a very strong growth
PAVM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 142.05% yearly.
EPS Next Y108.83%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-96.01%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
PAVM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PAVM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PAVM's earnings are expected to grow with 26.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for PAVM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.3186
-0.01 (-3.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.64%
Inst Owner Change25.32%
Ins Owners4.91%
Ins Owner Change15.5%
Market Cap8.81M
Revenue(TTM)3.00M
Net Income(TTM)70.05M
Analysts82.5
Price Target12.24 (3741.81%)
Short Float %2.15%
Short Ratio0.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-50.83%
Min EPS beat(2)-458.07%
Max EPS beat(2)356.41%
EPS beat(4)2
Avg EPS beat(4)4.93%
Min EPS beat(4)-458.07%
Max EPS beat(4)356.41%
EPS beat(8)4
Avg EPS beat(8)-2.84%
EPS beat(12)7
Avg EPS beat(12)1.55%
EPS beat(16)7
Avg EPS beat(16)-3.09%
Revenue beat(2)0
Avg Revenue beat(2)-31.37%
Min Revenue beat(2)-41.18%
Max Revenue beat(2)-21.57%
Revenue beat(4)0
Avg Revenue beat(4)-42.93%
Min Revenue beat(4)-98.31%
Max Revenue beat(4)-10.67%
Revenue beat(8)1
Avg Revenue beat(8)-22.75%
Revenue beat(12)2
Avg Revenue beat(12)-30.74%
Revenue beat(16)2
Avg Revenue beat(16)-36.71%
PT rev (1m)4.35%
PT rev (3m)4.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)100%
Revenue NQ rev (3m)100%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 8.63 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.22 | ||
| P/tB | 0.22 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.04
BVpS1.48
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 159.59% | ||
| ROE | 171.73% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 6867.55% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 6.45% | ||
| Cap/Sales | 2.35% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | -8.37 |
F-Score4
WACC6%
ROIC/WACCN/A
Cap/Depr(3y)25.15%
Cap/Depr(5y)202.92%
Cap/Sales(3y)138.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.14%
EPS Next Y108.83%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.15%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%
Revenue Next Year-96.01%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
EBIT growth 1Y54.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year114.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.3%
OCF growth 3YN/A
OCF growth 5YN/A
PAVMED INC / PAVM FAQ
What is the fundamental rating for PAVM stock?
ChartMill assigns a fundamental rating of 3 / 10 to PAVM.
Can you provide the valuation status for PAVMED INC?
ChartMill assigns a valuation rating of 1 / 10 to PAVMED INC (PAVM). This can be considered as Overvalued.
Can you provide the profitability details for PAVMED INC?
PAVMED INC (PAVM) has a profitability rating of 2 / 10.
Can you provide the financial health for PAVM stock?
The financial health rating of PAVMED INC (PAVM) is 2 / 10.
Can you provide the dividend sustainability for PAVM stock?
The dividend rating of PAVMED INC (PAVM) is 0 / 10 and the dividend payout ratio is 0%.